Riskpilot← Back to searchSign inGet full accessDr. Stephan L. Haas Hälsa AB
ABActiveOrg 5591033419Maria Sandels Gränd 4Tertiary education · NACE 8540Est. 20171 employees
Revenue 2024
SEK 403K
+38% vs 2023
EBITDA margin
4.0%
+351% vs 2023
Equity ratio
63.8%
Financial strength
Net profit 2024
SEK 10K
+224% vs 2023
| Revenue | SEK 403K | +38% |
| EBITDA | SEK 16K | +351% |
| Net profit | SEK 10K | +224% |
| Total assets | SEK 410K | +0% |
| Equity | SEK 261K | +4% |
| Employees | 1 | — |
Legal name
Dr. Stephan L. Haas Hälsa AB
Org number
5591033419
Legal form
Aktiebolag
NACE code
8540 · Tertiary education
Founded
6 mars 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Utbildning av studenter, sjuksköterskor och läkare genom föreläsningar, seminarier eller kurser. Hälsovård i sluten- och öppenvård (mottagning, sjukhus) som internmedicinare och gastroenterolog.
Address
Maria Sandels Gränd 4
Email
st.haas@gmx.de
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 100 | 222 | 354 | 293 | 403 |
| Staff expenses | — | — | −21 | −71 | −59 |
| EBITDA | −143 | 51 | 200 | 4 | 16 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −143 | 51 | 200 | 4 | 16 |
| Net financials | — | — | −0 | 1 | −0 |
| Profit before tax | −144 | 51 | 200 | 4 | 16 |
| Tax | −0 | −0 | −25 | −1 | −6 |
| Net profit | −144 | 51 | 175 | 3 | 10 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 155 | 222 | 446 | 408 | 410 |
| Equity | 23 | 73 | 248 | 251 | 261 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 132 | 149 | 198 | 157 | 148 |
| Total debt | 132 | 149 | 198 | 157 | 148 |
EBITDA margin
4.0%
This company
15.8%
Market median
-75% vs market
20202024
Equity ratio
63.8%
This company
38.2%
Market median
+67% vs market
20202024
Return on equity
3.8%
This company
18.4%
Market median
-79% vs market
20202024
Net profit margin
2.5%
This company
8.1%
Market median
-69% vs market
20202024
Asset turnover
0.98×
This company
1.12×
Market median
+13% vs market
20202024
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Stephan L. Haas Hälsa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Stephan Rafael Ludwig Haas | Board of Directors | 0 companies |
| Sahar Azodi Ghajar | Deputy Board Member | 0 companies |